Bicyclic-fused heteroaryl or aryl compounds

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclo...

Full description

Saved in:
Bibliographic Details
Main Authors BUNNAGE, MARK EDWARD, LOWE, MICHAEL DENNIS, LEE, ARTHUR, LOVERING, FRANK ELDRIDGE, PATNY, AKSHAY, SAIAH, EDDINE, PAPAIOANNOU, NIKOLAOS, ZAPF, CHRISTOPH WOLFGANG, LEE, KATHERINE LIN, PIERCE, BETSY SUSAN, VARGAS, RICHARD, TRZUPEK, JOHN DAVID, GOLDBERG, JOEL ADAM, HAN, SEUNGIL, HUANG, HORNGIH, HEPWORTH, DAVID, MATHIAS, JOHN PAUL, WANG, XIAOLUN, ANDERSON, DAVID RANDOLPH, STROHBACH, JOSEPH WALTER, GAVRIN, LORI KRIM, WRIGHT, STEPHEN WAYNE, CURRAN, KEVIN JOSEPH, DEHNHARDT, CHRISTOPH MARTIN
Format Patent
LanguageChinese
English
Published 01.11.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Bibliography:Application Number: TW20154111016